评估己内酰胺对肠道外稀释剂的污染。

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY American Journal of Health-System Pharmacy Pub Date : 2024-11-22 DOI:10.1093/ajhp/zxae204
Christophe Curti, Elise D'Huart, Edouard Lamy, Nicolas Primas, Cyril Fersing, Charleric Bornet, Nathalie Martin, Bertrand Pourroy, Patrice Vanelle
{"title":"评估己内酰胺对肠道外稀释剂的污染。","authors":"Christophe Curti, Elise D'Huart, Edouard Lamy, Nicolas Primas, Cyril Fersing, Charleric Bornet, Nathalie Martin, Bertrand Pourroy, Patrice Vanelle","doi":"10.1093/ajhp/zxae204","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A leachable cyclic amide (caprolactam) can be found in normal saline (NS) and 5% dextrose in water (D5W) plastic bags widely used in clinical practice if they contain polyamide in a multilayer sheeting. This contamination and the parameters that could influence its content have never been studied in a public work such as a scientific publication.</p><p><strong>Methods: </strong>Two independent laboratories validated a caprolactam dosing method and studied contamination levels in several containers.</p><p><strong>Results: </strong>Caprolactam content in multilayer polypropylene/polyamide/polypropylene plastic bags ranged from a mean (SD) of 5.43 (0.21) mg/L (D5W 1,000 mL) to 22.83 (1.26) mg/L (NS 50 mL). NS and D5W can be intravenously administered with a total daily dose of 3 L, corresponding to a minimal daily dose of 16.3 mg of caprolactam.</p><p><strong>Conclusion: </strong>The high levels of contamination we have reported and the possibility of administering caprolactam to high-risk patients (eg, neonates, the elderly) should make it imperative for pharmaceutical companies to communicate publicly on the safety of caprolactam.</p>","PeriodicalId":7577,"journal":{"name":"American Journal of Health-System Pharmacy","volume":" ","pages":"e770-e776"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of parenteral diluent contamination by caprolactam.\",\"authors\":\"Christophe Curti, Elise D'Huart, Edouard Lamy, Nicolas Primas, Cyril Fersing, Charleric Bornet, Nathalie Martin, Bertrand Pourroy, Patrice Vanelle\",\"doi\":\"10.1093/ajhp/zxae204\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>A leachable cyclic amide (caprolactam) can be found in normal saline (NS) and 5% dextrose in water (D5W) plastic bags widely used in clinical practice if they contain polyamide in a multilayer sheeting. This contamination and the parameters that could influence its content have never been studied in a public work such as a scientific publication.</p><p><strong>Methods: </strong>Two independent laboratories validated a caprolactam dosing method and studied contamination levels in several containers.</p><p><strong>Results: </strong>Caprolactam content in multilayer polypropylene/polyamide/polypropylene plastic bags ranged from a mean (SD) of 5.43 (0.21) mg/L (D5W 1,000 mL) to 22.83 (1.26) mg/L (NS 50 mL). NS and D5W can be intravenously administered with a total daily dose of 3 L, corresponding to a minimal daily dose of 16.3 mg of caprolactam.</p><p><strong>Conclusion: </strong>The high levels of contamination we have reported and the possibility of administering caprolactam to high-risk patients (eg, neonates, the elderly) should make it imperative for pharmaceutical companies to communicate publicly on the safety of caprolactam.</p>\",\"PeriodicalId\":7577,\"journal\":{\"name\":\"American Journal of Health-System Pharmacy\",\"volume\":\" \",\"pages\":\"e770-e776\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2024-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Health-System Pharmacy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ajhp/zxae204\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Health-System Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajhp/zxae204","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

免责声明:为了加快文章的发表,AJHP在接受稿件后会尽快将其发布到网上。被录用的稿件已经过同行评审和校对,但在进行技术格式化和作者校对之前会在网上发布。目的:在临床上广泛使用的生理盐水(NS)和5%葡萄糖水溶液(D5W)塑料袋中,如果含有多层聚酰胺,就会发现一种可浸出的环酰胺(己内酰胺)。这种污染以及可能影响其含量的参数从未在科学出版物等公开出版物中进行过研究:方法:两个独立实验室验证了一种己内酰胺剂量方法,并研究了多个容器中的污染水平:多层聚丙烯/聚酰胺/聚丙烯塑料袋中的己内酰胺含量从平均值(SD)5.43 (0.21) mg/L(D5W 1,000 mL)到 22.83 (1.26) mg/L(NS 50 mL)不等。NS和D5W的静脉注射每日总剂量为3升,相当于16.3毫克己内酰胺的最低日剂量:结论:我们所报告的污染水平之高以及高危患者(如新生儿、老年人)使用己内酰胺的可能性,使得制药公司必须就己内酰胺的安全性进行公开交流。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluation of parenteral diluent contamination by caprolactam.

Purpose: A leachable cyclic amide (caprolactam) can be found in normal saline (NS) and 5% dextrose in water (D5W) plastic bags widely used in clinical practice if they contain polyamide in a multilayer sheeting. This contamination and the parameters that could influence its content have never been studied in a public work such as a scientific publication.

Methods: Two independent laboratories validated a caprolactam dosing method and studied contamination levels in several containers.

Results: Caprolactam content in multilayer polypropylene/polyamide/polypropylene plastic bags ranged from a mean (SD) of 5.43 (0.21) mg/L (D5W 1,000 mL) to 22.83 (1.26) mg/L (NS 50 mL). NS and D5W can be intravenously administered with a total daily dose of 3 L, corresponding to a minimal daily dose of 16.3 mg of caprolactam.

Conclusion: The high levels of contamination we have reported and the possibility of administering caprolactam to high-risk patients (eg, neonates, the elderly) should make it imperative for pharmaceutical companies to communicate publicly on the safety of caprolactam.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.90
自引率
18.50%
发文量
341
审稿时长
3-8 weeks
期刊介绍: The American Journal of Health-System Pharmacy (AJHP) is the official publication of the American Society of Health-System Pharmacists (ASHP). It publishes peer-reviewed scientific papers on contemporary drug therapy and pharmacy practice innovations in hospitals and health systems. With a circulation of more than 43,000, AJHP is the most widely recognized and respected clinical pharmacy journal in the world.
期刊最新文献
Recent and anticipated novel drug approvals (4Q 2024 through 3Q 2025). A call to action: Studying the shortened duration of ceftriaxone for inpatient management of acute uncomplicated cystitis. Impact of a pharmacist-led intervention on prostate cancer illness perception. Pharmacotherapy considerations for pediatric acute agitation management in the emergency department. Central lines, aseptic batching services, and infection rates: A pharmacy-led initiative of intravenous tube priming within a NICU.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1